3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
3
Pain
3
Colorectal Neoplasms
2
Supratentorial Neoplasms
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pancreatic Ductal Adenocarcinoma
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Meningioma
1
Lung Neoplasms
1
Liver Neoplasms
1
Liver Diseases
1
Colonic Neoplasms
1
Cancer Pain
1
Breast Neoplasms
1
Benign Gynecologic Neoplasm
1
Agnosia
1
Acute Pain
1
Abdominal Neoplasms
1
Interventions
Bupivacaine
4
Pregabalin
3
Ketamine
3
parecoxib
2
Tramadol
2
Injections, Epidural
2
Fentanyl
2
Ethanol
2
Dexmedetomidine
2
Acetaminophen
2
oxycodone-acetaminophen
1
loxoprofen
1
Surveys and Questionnaires
1
Standard of Care
1
Ropivacaine
1
Rehabilitation
1
Radiofrequency Ablation
1
Passive Cutaneous Anaphylaxis
1
Orphenadrine
1
Musculoskeletal Manipulations
1
Morphine
1
Mindfulness-Based Cognitive Therapy
1
Methadone
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Hydromorphone
1
Hydrocodone
1
Hospitals
1
Gabapentin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Agnosia
×
Ropivacaine
×
Clear all
NCT04879004
2021-05-10
EFFECT
Democritus University of Thrace
Phase NA
Unknown
40 enrolled